Game On Mole is back this summer!
13 November 2020
The edgy Game On Mole campaign leverages the iconic Aussie catch-cry ‘game on, mole’, encouraging young Australians to check their skin for changes and then seek medical advice if they notice any changes.
It calls on Aussies to don a limited-edition ‘Game On Mole’ T-shirt and share selfies on social media tagged #gameonmole to generate life-saving conversations around sun safety and skin health.
With one Australian expected to be diagnosed with melanoma every half an hour this year, Olympian and melanoma survivor, Cate Campbell, is once again fronting the campaign.
‘I am living proof that early detection is vital to saving lives from melanoma. We need to be having discussions about sun-safety and checking your skin for changes, and I encourage all Aussies to buy a t-shirt, wear it proudly, and start those life-saving conversations.’
CEO of Melanoma Institute Australia, Matthew Browne, said the campaign uses Australian humour to relay a serious message.
‘We know Australians love a laugh almost as much as they love soaking up the sun. But melanoma is no laughing matter, with one Australian dying from the disease every five hours and it being the most common cancer impacting 15 to 39 year olds.
‘The strength of this campaign lies in its capacity to empower all Australians to be a part of the solution by wearing a t-shirt that begs the question ‘what is that about?’ It’s a great conversation starter about what is largely a preventable disease.’
This year’s campaign includes a range of new t-shirt designs giving people a variety of ways to spread the ‘Game On Mole’ message. T-shirt sales also help fund ongoing research by Melanoma Institute Australia into new treatments to save lives from melanoma.
Go to www.gameonmole.com.au to buy the t-shirt and for life-saving information. Follow the campaign on socials on facebook and Instagram.
For more information, please contact:
Jennifer Durante |Melanoma Institute Australia | 0412 798 990 | jennifer.durante@melanoma.org.au
Dr James Wilmott awarded for outstanding cancer research
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
Community invests in MIA's new trial
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
New trial giving options
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Melanoma research summary from ASCO
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
Updated privacy policy
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Can cognitive technology assist with melanoma identification?
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
'4 Questions With...' Series
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
Stop the Spread campaign shortlisted
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.
A meeting of the minds
MIA's doctors are converging on Chicago this week along with 40,000 delegates from around the globe at the biggest oncology conference in the world.
MIA's Dermatology services expanded
We are pleased to announce a recent expansion to the dermatology services at Melanoma Institute Australia.
5 Minutes with Maria Gonzalez
This International Clinical Trials Day we reflect on the importance of clinical trials and the people who dedicate their lives to helping melanoma patients today and in the future.
Melanoma eBook to educate GPs
MIA has launched its first eBook Melanoma Essentials – A Concise Guide, a resource for GPs and other medical, nursing and allied professionals to help them effectively diagnose and manage cases.
5 Minutes with Dr Scot Ebbinghaus
Dr Scot Ebbinghaus chats to us about an exciting clinical trial at MIA and where melanoma treatment is headed in the future.
Opdivo available on PBS for advanced melanoma patients
A new melanoma treatment has been listed on the PBS today, giving another option for advanced melanoma patients.
5 Minutes with Dr Louise Jackett
MIA's Pathology Fellow Dr Louise Jackett tells us why she's joined our fellowship program to learn from the best.
MIA patient's plight highlighted in ABC series
MIA doctors and patient have featured in the final episode of ABC’s ground-breaking series Keeping Australia Alive.
Recruiting: Pregnancy and moles study
Specialist dermatologists at MIA are researching moles during pregnancy and we are looking for study recruits.
The role of radiotherapy in melanoma
New research is re-writing the textbooks on what we know about melanoma by highlighting the effectiveness of radiotherapy as a treatment, reversing a long-held belief that melanoma was resistant to radiotherapy.
Australian melanoma rates take the silver – and that's good news
However, Australia's burden of melanoma will stay very high over the next 15 years unless we do more. MIA's Professor Graham Mann explains.